Latest news
Redeye: Iconovo company presentation
Johan Wäborg, CEO of Iconovo, presented what's going on at Iconovo at the Redeye Theme: Medtech & Diagnostics Event 2024. What's going on?
Please…
BIOSTOCK: Inhalationsspecialisterna Iconovo tar in kapital (Swedish only)
En intranasal fetmabehandling under utveckling, en generisk utmanare till astmaprodukten Symbicort och samtal med potentiella partners står på agendan…
Press releases
Jul 12, 2021, 09:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Jul 05, 2021, 14:59
News
IR
Swedish
Corporate Information
Other Corporate Information
Jul 01, 2021, 22:06
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 22:06
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
May 26, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 26, 2021, 08:00
News
IR
English
Corporate Information
Other Corporate Information
May 24, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
May 20, 2021, 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 20, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
May 19, 2021, 10:07
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 17, 2021, 10:45
News
IR
Swedish
Corporate Information
Other Corporate Information
May 17, 2021, 10:45
News
IR
English
Corporate Information
Other Corporate Information
May 14, 2021, 07:05
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 14, 2021, 07:05
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Apr 30, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Apr 29, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se